Peter Adamson, MD on Isatuximab-irfc for Patients with Relapsed Refractory MM

Peter Adamson, MD of Sanofi discusses the FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma